| Project/Area Number |
12671014
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Hematology
|
|---|
| Research Institution | Kawasaki Medical School |
|---|
Principal Investigator |
WADA Hideho Division of Hematology, Department of Medicine, Kawasaki Medical School, Assistant professor, 医学部, 講師 (70191830)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
YAWATA Yoshihito Department of Care Work, Kawasaki College of Allied Health Professions, Professor, 介護福祉科, 教授 (70069011)
SUGIHARA Takashi Division of Hematology, Department of Medicine, Kawasaki Medical School, Professor, 医学部, 教授 (60140505)
山田 治 川崎医科大学, 医学部, 助教授 (50104790)
賀来 万由美 川崎医科大学, 医学部, 助手 (20319940)
|
|---|
| Project Period (FY) |
2000 – 2002
|
| Project Status |
Completed (Fiscal Year 2002)
|
| Budget Amount *help |
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2002: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2001: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 2000: ¥1,800,000 (Direct Cost: ¥1,800,000)
|
|---|
| Keywords | DNA methylation / promoter / red cell membrane / protein 4.2 / β-spectrin / band3 / UT-7 / Epo / 5'-CpG-3' sites / DNA meth lation / β-sectrin / methylation / protein4.2 / band3 / 5'-CpG-3'sites |
|---|
| Research Abstract |
The state of methylation of the 5'-CpG-3' sites is known to be linked to the regulation of promoter function by modulating DNA-protein interactions and to the structure of chromatin. As part of a project to determine methylation patterns in the human genome, the methylation profiles were examined in genes for the human erythroid membrane proteins; protein 4.2 (P4.2), gene (ELB42), band 3 (B3), gene (EPB3), and β -spectrin (β -Sp), gene (SPTB). The bisulfite protocol of the genomic sequencing method was applied. (1) In the DNA from peripheral white blood cells, the promoter regions of EPB3 and ELB42 were extensively methylated, but the promoter of SPTB was totally unmethylated. (2) During erythroid differentiation, (I) ELB42 was unmethylated in DNAs from the cell line UT-7/Epo, but became methylated (55-93%) in cultured erythroblasts from peripheral BFU-E. The Mrna from ELB42 was first detected in early erythroblasts and protein 4.2 was expressed in late erythroblasts. (ii) EPB3 was consistently methylated in UT-7/Epo and also in cultured erythroblasts from burst forming unit erythroid (BFU-E) from peripheral blood. EPB3 and ELB42 were efficiently transcribed in UT-7 cells only after erythropoietin stimulation. (iii) SPTB remained unmethylated in DNAs from UT-7/Epo and cultured erythroblasts. (3) We also investigated methylation profiles in peripheral white blood cells from patients with erythroid diseases, like complete P4.2 deficiency due to ELB42 mutations, hereditary spherocytosis with EPB3 mutations, and hereditary elliptocytosis with SPTB mutations. The methylation profiles of the promoter regions of these three genes were essentially identical to those in healthy individuals
|
